158 related articles for article (PubMed ID: 36448588)
1. Knockdown of kinesin family member 2C restricts cell proliferation and induces cell cycle arrest in gastric cancer.
Li S; Ma Y; Wu C; Hou X
Histol Histopathol; 2023 Aug; 38(8):907-916. PubMed ID: 36448588
[TBL] [Abstract][Full Text] [Related]
2. KIF2C is a prognostic biomarker associated with immune cell infiltration in breast cancer.
Liu S; Ye Z; Xue VW; Sun Q; Li H; Lu D
BMC Cancer; 2023 Apr; 23(1):307. PubMed ID: 37016301
[TBL] [Abstract][Full Text] [Related]
3. Involvement of kinesin family member 2C/mitotic centromere-associated kinesin overexpression in mammary carcinogenesis.
Shimo A; Tanikawa C; Nishidate T; Lin ML; Matsuda K; Park JH; Ueki T; Ohta T; Hirata K; Fukuda M; Nakamura Y; Katagiri T
Cancer Sci; 2008 Jan; 99(1):62-70. PubMed ID: 17944972
[TBL] [Abstract][Full Text] [Related]
4. Large-Scale Transcriptome Data Analysis Identifies KIF2C as a Potential Therapeutic Target Associated With Immune Infiltration in Prostate Cancer.
Zhang P; Gao H; Ye C; Yan R; Yu L; Xia C; Yang D
Front Immunol; 2022; 13():905259. PubMed ID: 35720323
[TBL] [Abstract][Full Text] [Related]
5. KIF2C Is a Novel Prognostic Biomarker and Correlated with Immune Infiltration in Endometrial Cancer.
An L; Zhang J; Feng D; Zhao Y; Ouyang W; Shi R; Zhou X; Yu Z; Wei S; Min J; Wang H
Stem Cells Int; 2021; 2021():1434856. PubMed ID: 34650608
[TBL] [Abstract][Full Text] [Related]
6. Kinesin family member 2C aggravates the progression of hepatocellular carcinoma and interacts with competing endogenous RNA.
Zhang GP; Shen SL; Yu Y; Yue X; Hu WJ; Li SQ
J Cell Biochem; 2020 Nov; 121(11):4419-4430. PubMed ID: 32056305
[TBL] [Abstract][Full Text] [Related]
7. miR-139-3p/Kinesin family member 18B axis suppresses malignant progression of gastric cancer.
Ke H; Wu S; Zhang Y; Zhang G
Bioengineered; 2022 Feb; 13(2):4528-4536. PubMed ID: 35137670
[TBL] [Abstract][Full Text] [Related]
8. KIF2C accelerates the development of non-small cell lung cancer and is suppressed by miR-186-3p via the AKT-GSK3β-β-catenin pathway.
Guo J; Zhang W; Sun L; Yu H; Wang Y; Feng L; Yang H
Sci Rep; 2023 May; 13(1):7288. PubMed ID: 37142638
[TBL] [Abstract][Full Text] [Related]
9. Activation of the TGF-β1/Smad signaling by KIF2C contributes to the malignant phenotype of thyroid carcinoma cells.
Lin Q; Qi Q; Hou S; Chen Z; Jiang N; Zhang L; Lin C
Tissue Cell; 2021 Dec; 73():101655. PubMed ID: 34624565
[TBL] [Abstract][Full Text] [Related]
10. KIF15 promotes the evolution of gastric cancer cells through inhibition of reactive oxygen species-mediated apoptosis.
Tao J; Sun G; Li Q; Zhi X; Li Z; He Z; Chen H; Zhou A; Ye J; Xu G; Guan W; Zhang W
J Cell Physiol; 2020 Dec; 235(12):9388-9398. PubMed ID: 32342525
[TBL] [Abstract][Full Text] [Related]
11. Multi-omics analysis of kinesin family member 2C in human tumors: novel prognostic biomarker and tumor microenvironment regulator.
Zhang B; Liu P; Li Y; Hu Q; Li H; Pang X; Wu H
Am J Cancer Res; 2022; 12(11):4954-4976. PubMed ID: 36504885
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Kinesin Family Member 2C as a Proto-Oncogene in Cervical Cancer.
Yang J; Wu Z; Yang L; Jeong JH; Zhu Y; Lu J; Wang B; Wang N; Wang Y; Shen K; Li R
Front Pharmacol; 2021; 12():785981. PubMed ID: 35153749
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of the effects of KIF2C on prognosis, biological functions and immune infiltration in PAAD.
Xiong J; Wu R; He A; Hou P; Wang J; Zhang R; Liao W; Wu L; Li E
Tissue Cell; 2022 Oct; 78():101900. PubMed ID: 36029726
[TBL] [Abstract][Full Text] [Related]
14. NY-CO-58/KIF2C is overexpressed in a variety of solid tumors and induces frequent T cell responses in patients with colorectal cancer.
Gnjatic S; Cao Y; Reichelt U; Yekebas EF; Nölker C; Marx AH; Erbersdobler A; Nishikawa H; Hildebrandt Y; Bartels K; Horn C; Stahl T; Gout I; Filonenko V; Ling KL; Cerundolo V; Luetkens T; Ritter G; Friedrichs K; Leuwer R; Hegewisch-Becker S; Izbicki JR; Bokemeyer C; Old LJ; Atanackovic D
Int J Cancer; 2010 Jul; 127(2):381-93. PubMed ID: 19937794
[TBL] [Abstract][Full Text] [Related]
15. KIF3C: an emerging biomarker with prognostic and immune implications across pan-cancer types and its experiment validation in gastric cancer.
Zhong Q; Hong W; Xiong L
Aging (Albany NY); 2024 Mar; 16(7):6163-6187. PubMed ID: 38552217
[TBL] [Abstract][Full Text] [Related]
16. Effect of KIF22 on promoting proliferation and migration of gastric cancer cells via MAPK-ERK pathways.
Yu ZY; Jiang XY; Zhao RR; Qin JJ; Luo CJ; Ren YX; Ren W; Ma ZJ; Jiao ZY
Chin Med J (Engl); 2020 Apr; 133(8):919-928. PubMed ID: 32187050
[TBL] [Abstract][Full Text] [Related]
17. KIF2A promotes the progression via AKT signaling pathway and is upregulated by transcription factor ETV4 in human gastric cancer.
Zhang X; Wang Y; Liu X; Zhao A; Yang Z; Kong F; Sun L; Yu Y; Jiang L
Biomed Pharmacother; 2020 May; 125():109840. PubMed ID: 32106376
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-149 inhibits proliferation and cell cycle progression through the targeting of ZBTB2 in human gastric cancer.
Wang Y; Zheng X; Zhang Z; Zhou J; Zhao G; Yang J; Xia L; Wang R; Cai X; Hu H; Zhu C; Nie Y; Wu K; Zhang D; Fan D
PLoS One; 2012; 7(10):e41693. PubMed ID: 23144691
[TBL] [Abstract][Full Text] [Related]
19. KIF14 promotes tumor progression and metastasis and is an independent predictor of poor prognosis in human gastric cancer.
Yang Z; Li C; Yan C; Li J; Yan M; Liu B; Zhu Z; Wu Y; Gu Q
Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):181-192. PubMed ID: 30404039
[TBL] [Abstract][Full Text] [Related]
20. KIF2C is a Biomarker Correlated With Prognosis and Immunosuppressive Microenvironment in Human Tumors.
Zhang X; Li Y; Hu P; Xu L; Qiu H
Front Genet; 2022; 13():891408. PubMed ID: 35685442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
